Susquehanna International Group
VAXX

Susquehanna International Group’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Susquehanna International Group’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-14,766
Closed -$12.6K – 13698
2023
Q4 		$12.6K Buy
+14,766
New +$14.3K ﹤0.01% 12042
2023
Q3 		– Sell
-12,411
Closed -$31.3K – 13267
2023
Q2 		$31.3K Sell
12,411
-291,721
-96% -$618K ﹤0.01% 11504
2023
Q1 		$690K Buy
+304,132
New +$771K ﹤0.01% 7757

Other funds holding VAXX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
SAS
Stelac Advisory Services New York $494M AUM 23.25% 1-Year Est. Return

Susquehanna International Group's VAXX Position: Q1 2024 in Review

Susquehanna International Group sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q1 2024, closing a stake of 14,766 shares — an estimated $12.6K sold.

Susquehanna International Group first reported a position in VAXX in Q1 2023 and held it in 3 quarters. The position peaked at $690K in Q1 2023. 58 funds tracked by Wall St. Rank hold VAXX as of Q1 2024.

  • Susquehanna International Group reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 14,766 Vaxxinity, Inc. Class A Common Stock shares in Q1 2024, an estimated $12.6K.
  • Susquehanna International Group first reported a position in Vaxxinity, Inc. Class A Common Stock in Q1 2023 and held it in 3 quarters.
  • Susquehanna International Group's Vaxxinity, Inc. Class A Common Stock position peaked at $690K in Q1 2023.
  • 58 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.